Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Hope Clinical Research operates as a clinical trial site conducting industry-sponsored and investigator-led trials across multiple therapeutic areas. The facility has received an FDA audit with no significant deficiencies—a distinction achieved by only about one-fifth of US sites. Current studies include those targeting major depressive disorder, schizophrenia, Alzheimer’s disease, migraine, and obsessive-compulsive disorder. The clinic participates in both early-phase and late-phase research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Hope Clinical Research.